GLP1 Receptor Agonists

26.5 Percent of Adults With Diabetes Used GLP-1 RA Injectables in 2024

26.5 Percent of Adults With Diabetes Used GLP-1 RA Injectables in 2024

Aug 14, 2025

1 min read

Potential Benefits Seen for GLP-1 RAs in Hidradenitis Suppurativa Management

Dermatology Special

Potential Benefits Seen for GLP-1 RAs in Hidradenitis Suppurativa Management

Aug 13, 2025

2 min read

GLP-1 Receptor Agonists May Reduce Complications of Diabetic Retinopathy

GLP-1 Receptor Agonists May Reduce Complications of Diabetic Retinopathy

Aug 12, 2025

2 min read

1 in 10 Americans Has Used GLP-1 Drugs For Weight Loss, Survey Says

1 in 10 Americans Has Used GLP-1 Drugs For Weight Loss, Survey Says

Dennis Thompson

Aug 08, 2025

2 min read

Study IDs Barriers to GLP-1 Receptor Agonist Use in Adolescents, Young Adults

Study IDs Barriers to GLP-1 Receptor Agonist Use in Adolescents, Young Adults

Aug 07, 2025

2 min read

GLP-1 Receptor Agonist Use Linked to Nonarteritic Anterior Ischemic Optic Neuropathy

GLP-1 Receptor Agonist Use Linked to Nonarteritic Anterior Ischemic Optic Neuropathy

Aug 05, 2025

1 min read

GLP-1 Receptor Agonist Use Linked to Lower Mortality in Seniors With Cancer, T2D

GLP-1 Receptor Agonist Use Linked to Lower Mortality in Seniors With Cancer, T2D

Jul 24, 2025

2 min read

GLP-1 Receptor Agonists Tied to Decrease in T2DM-Related Dementia Risk

GLP-1 Receptor Agonists Tied to Decrease in T2DM-Related Dementia Risk

Jul 23, 2025

1 min read

Risk for Dementia, Ischemic Stroke, Mortality Lower With GLP-1 Receptor Agonists in T2D, Obesity

Risk for Dementia, Ischemic Stroke, Mortality Lower With GLP-1 Receptor Agonists in T2D, Obesity

Jul 22, 2025

1 min read

Read More

www.healthday.com